Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Drug Companies Expected To Outperform Device Makers In 2010 - Morgan Stanley Valuation Overview

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - With a strong IPO performance for the Chinese healthcare sector in 2009, the total market cap for Chinese healthcare companies has reached $145 billion with 185 companies listed globally, according to the first China Healthcare Valuation Map, developed by Morgan Stanley research group in Hong Kong

You may also be interested in...



China Healthcare Industry Will See A Strong 2010: Morgan Stanley

SHANGHAI - Backed by Beijing's $124 billion investment in health system reforms over the next several years, the entire healthcare industry in China will see strong growth in 2010, say analysts from Morgan Stanley's research department

The Year Of The Tiger Looking Strong For IPOs In China Following Sinopharm Success

HONG KONG - Concerns over valuation seem to be doing little to dampen enthusiasm for new Chinese pharmaceutical related stocks and the result is a minefield of opportunities on very shaky ground

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

SC073054

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel